FDA.reportPublic FDA data

probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet

RxCUI
2717843
RxNorm name
probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet
Display name
probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet
Full name
probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ORLYNVAHSULOPENEM ETZADROXIL AND PROBENECIDITERUM THERAPEUTICS US LIMITED24c451c0-4cfb-37f3-e063-6394a90a895e2025-12-06Warnings, Adverse reactionsExact identifier
rxcui: 2717843

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
24c451c0-4cfb-37f3-e063-6394a90a895eprobenecid 500 MG / sulopenem etzadroxil 500 MG Oral TabletPSN6These highlights do not include all the information needed to use ORLYNVAH TM safely and effectively. See full prescribing information for ORLYNVAH TM . ORLYNVAH TM (sulopenem etzadroxil and probenecid) tablets, for oral use Initial U.S. Approval: 202420251206
24c451c0-4cfb-37f3-e063-6394a90a895eprobenecid 500 MG / sulopenem etzadroxil 500 MG Oral TabletSCD6These highlights do not include all the information needed to use ORLYNVAH TM safely and effectively. See full prescribing information for ORLYNVAH TM . ORLYNVAH TM (sulopenem etzadroxil and probenecid) tablets, for oral use Initial U.S. Approval: 202420251206